CANARY in the field
CANARY is currently deployed for applications in Biodefense, Food Safety, Agriculture and Emerging disease. Here’s how CANARY can help you:
CANARY® is a tested and proven method of pathogen threat detection, providing users with an unprecedented level of speed and sensitivity in both commercial and defence applications. Originally developed by MIT, CANARY technology allows the detection of a wide range of pathogens including bacteria, viruses and toxins.
CANARY breaks though the limitations of current laboratory-based biological testing methods allowing detection capabilities to be conducted on-site or at the place of operation. It combines the sensitivity of PCR with the speed of Lateral Flow, allowing users to accurately test for tiny amounts of pathogen in minutes. The method requires very few materials, time, and minimal scientific expertise.
CANARY uses a genetically engineered immune cell called a “biosensor” to identify and bind to a specific target. When a pathogen is found, a reaction starts causing the biosensor to luminesce. By measuring light output from the cell, we can tell if the target biological is present in the sample.
How does our CANARY® technology detect COVID-19 in the air? Read our white paper to find out.
CANARY is currently deployed for applications in Biodefense, Food Safety, Agriculture and Emerging disease. Here’s how CANARY can help you:
EARLY WARNING · HEALTHY EMPLOYEES
SAVE MONEY · HEALTHY CUSTOMERS · AVOID RECALLS
MINIMISE CROP LOSS · SAVE MONEY
TRACK DISEASES · MONITOR RESPONSE · PROMOTE HEALTH